Clincosm LogoSign in Get a demo

breast cancer

Showing NaN - NaN of 217
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer Trial in Worldwide (Dato-DXd, Durvalumab, Pembrolizumab)

Not yet recruiting
  • Breast Cancer
  • Jonesboro, Arkansas
  • +142 more
Oct 31, 2023

Breast Cancer Trial in Worldwide (Dato-DXd, Durvalumab, Paclitaxel)

Not yet recruiting
  • Breast Cancer
  • Duarte, California
  • +111 more
Oct 23, 2023

Breast Cancer Trial in London (ONCOTYPE DX DCIS test)

Active, not recruiting
  • Breast Cancer
  • ONCOTYPE DX DCIS test
  • London, United Kingdom
    The Royal Marsden NHS Foundation Trust
Sep 13, 2023

Breast Cancer Trial in Worldwide (palliative surgery, therapeutic conventional surgery, palliative radiation therapy)

Completed
Has Results
  • Breast Cancer
  • Stage IV Breast Cancer
  • palliative surgery
  • +3 more
  • Mobile, Alabama
  • +376 more
Jan 6, 2023

Breast Cancer Trial in Worldwide (GDC-9545, Palbociclib, LHRH Agonist)

Active, not recruiting
  • Breast Cancer
  • Aurora, Colorado
  • +23 more
Jan 30, 2023

Breast Cancer Trial in Worldwide (Dato-DXd, Paclitaxel, Nab-paclitaxel)

Recruiting
  • Breast Cancer
  • Duarte, California
  • +260 more
Jan 19, 2023

Breast Cancer Trial in Worldwide (Perjeta, Herceptin, Docetaxel)

Active, not recruiting
  • Breast Cancer
  • Bruxelles, Belgium
  • +55 more
Jan 18, 2023

Breast Cancer Trial in Worldwide (Dato-DXd, Durvalumab, Capecitabine)

Recruiting
  • Breast Cancer
  • Gilbert, Arizona
  • +165 more
Jan 17, 2023

Breast Cancer Trial in London (Tamoxifen Citrate 20Mg Tab, Placebo)

Active, not recruiting
  • Breast Cancer
  • Tamoxifen Citrate 20Mg Tab
  • Placebo
  • London, England, United Kingdom
    Queen Mary University of London
Jan 13, 2023

Cancer in Patients on Dapagliflozin and Other Antidiabetic

Recruiting
  • Breast Cancer
  • Bladder Cancer
    • Wilmington, Delaware
    • +3 more
    Jan 13, 2023

    Breast Cancer, Solid Tumor Trial in Worldwide (Inavolisib, Fulvestrant, Letrozole)

    Recruiting
    • Breast Cancer
    • Solid Tumor
    • Boston, Massachusetts
    • +12 more
    Jan 10, 2023

    Breast Cancer Trial in Worldwide (Atezolizumab, Trastuzumab Emtansine, Placebo)

    Recruiting
    • Breast Cancer
    • Alabaster, Alabama
    • +305 more
    Jan 10, 2023

    Breast Cancer Trial in Worldwide (Inavolisib, Placebo, Palbociclib)

    Recruiting
    • Breast Cancer
    • Tucson, Arizona
    • +228 more
    Jan 10, 2023

    Breast Cancer Trial in Worldwide (trastuzumab, trastuzumab emtansine)

    Active, not recruiting
    Has Results
    • Breast Cancer
    • Anchorage, Alaska
    • +275 more
    Dec 13, 2022

    Breast Cancer Trial in London ([18F]GE-226)

    Recruiting
    • Breast Cancer
    • [18F]GE-226
    • London, United Kingdom
      Imperial College Healthcare NHS Trust
    Jan 3, 2023

    Breast Cancer Trial in Worldwide (Ipatasertib, Placebo, Palbociclib)

    Active, not recruiting
    • Breast Cancer
    • Atlanta, Georgia
    • +19 more
    Dec 5, 2022

    Breast Cancer, Non-small Cell Lung Carcinoma Trial in Worldwide (Trastuzumab deruxtecan (DS-8201a), Pembrolizumab)

    Recruiting
    • Breast Cancer
    • Non-small Cell Lung Carcinoma
    • San Francisco, California
    • +24 more
    Nov 30, 2022

    Breast Cancer Trial in Worldwide (Dato-DXd, Capecitabine, Gemcitabine)

    Active, not recruiting
    • Breast Cancer
    • Duarte, California
    • +172 more
    Dec 1, 2022

    Breast Cancer Trial in Worldwide (Olaparib, Placebo)

    Active, not recruiting
    Has Results
    • Breast Cancer
    • Anchorage, Alabama
    • +698 more
    Nov 25, 2022

    Pancreatic Cancer, Colorectal Cancer, NSCLC Trial in United Kingdom (AVA6000)

    Recruiting
    • Pancreatic Cancer
    • +7 more
    • Glasgow, United Kingdom
    • +5 more
    Nov 24, 2022

    Solid Tumor, Breast Cancer, Cancer of Head and Neck Trial in Worldwide (RO6874281, Trastuzumab, Cetuximab)

    Completed
    • Solid Tumor
    • +2 more
    • Tucson, Arizona
    • +25 more
    Nov 21, 2022

    Follow-up in Early and Locally Advanced Breast Cancer Patients

    Active, not recruiting
    • Breast Cancer
      • Aalst, Belgium
      • +27 more
      Nov 16, 2022

      Breast Cancer Trial in Worldwide (Alpelisib, Fulvestrant, Letrozole)

      Active, not recruiting
      • Breast Cancer
      • Gilbert, Arizona
      • +93 more
      Nov 10, 2022

      Breast Cancer, Prostate Cancer, Quality of Life Trial in Worldwide (ASCAPE-based follow-up strategy)

      Recruiting
      • Breast Cancer
      • +4 more
      • ASCAPE-based follow-up strategy
      • Athens, Greece
      • +4 more
      Oct 28, 2022

      Breast Cancer Trial (GSK3326595)

      Completed
      • Breast Cancer
      • London, Ontario, Canada
        St. Joseph's Health Care London
      Oct 24, 2022